Vessel Restoration Therapy during Percutaneous Coronary Intervention with Bioresorbable Scaffold

Abstract

Permanent caging of the vessel with metal is still perceived as a limitation of drug eluting stents, in that it prevents late luminal enlargement, adaptive shear stress and late expansive remodeling [1]. Transient bioresorbable scaffolding prevents vessel acute closure and recoil, drug elution counteracts neointimal proliferation, and complete bioresorption after two to four years, together with vessel lumen enlargement, plaque/media reduction and vasomotion restoration, finally realises the paradigm of vascular restoration therapy [2].